Tenet Healthcare Corporation Notice of Annual Meeting & Proxy Statement

Total Page:16

File Type:pdf, Size:1020Kb

Tenet Healthcare Corporation Notice of Annual Meeting & Proxy Statement Tenet Healthcare Corporation 2018 Notice of Annual Meeting & Proxy Statement MESSAGE FROM OUR EXECUTIVE CHAIRMAN AND CHIEF EXECUTIVE OFFICER Dear Fellow Shareholders: 2017 was a year of significant transition for Tenet. During the year, we continued to focus on providing high-quality care to patients, innovating to meet the demands of today’s healthcare market, and driving operational and financial performance to maximize shareholder value. At the same time, it became necessary to make a number of changes, including at the senior management level, to transform and move the Company forward. I was appointed Executive Chairman and Chief Executive Officer in the fall and, since that time, we have taken swift and decisive actions: • Implemented enterprise-wide cost reduction initiatives expected to realize $125 million in cost savings in 2018 and $250 million of annualized run-rate cost savings by the end of 2018; • Initiated a process to explore a sale of Conifer Health Solutions;and • Announced plans to divest non-core hospital assets that are expected to yield over $1 billion of proceeds. At the same time, we made significant changes from a Board and governance standpoint. We have a strong history of regularly engaging with our shareholders to solicit feedback and take action in response. Based on feedback received from shareholders over the past several months, the Board: • Implemented a special meeting right for shareholders collectively owning 25% of our outstanding shares; • Continued its ongoing process of Board refreshment, which included the appointment of three independent directors in 2017; and • Terminated our short-term NOL rights plan ahead of its scheduled expiration at our 2018 annual meeting. In closing, 2017 was a year of significant progress and change across many aspects of our company. As we look forward to 2018, we are confident we have the right strategy, Board and governance in place to grow our business and to position Tenet for the future. Sincerely, Ronald A. Rittenmeyer Executive Chairman and Chief Executive Officer TENET HEALTHCARE CORPORATION 1445 Ross Avenue, Suite 1400 Dallas, Texas 75202 (469) 893-2200 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS to be held on Thursday, May 3, 2018 March 30, 2018 To Our Shareholders: Our Annual Meeting of Shareholders will be held on Thursday, May 3, 2018, at 8:00 a.m. Central Time at Tenet Corporate Headquarters, 1445 Ross Avenue, Suite 1400, Dallas, Texas 75202, for the following purposes: 1. To elect the eight directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director’s earlier resignation or removal. Your Board of Directors recommends a vote for each director nominee. 2. To vote, on an advisory basis, to approve the Company’s executive compensation. Your Board of Directors recommends a vote for this proposal. 3. To ratify the selection of Deloitte & Touche LLP as our independent registered public accountants for the year ending December 31, 2018. Your Board of Directors recommends a vote for this proposal. 4. To vote on a shareholder proposal regarding an independent board chairman, if properly presented at the meeting. Your Board of Directors recommends a vote against this proposal. 5. To transact any other business that properly comes before the meeting or any adjournment or postponement. Only shareholders of record of our common stock at the close of business on March 29, 2018 are entitled to vote at the Annual Meeting. It is important that your shares be represented and voted at the Annual Meeting. You may vote your shares via the Internet, by telephone or by completing and returning a proxy card. Specific voting instructions are set forth in the “General Information Regarding the Annual Meeting and Voting” section of the accompanying Proxy Statement and on the proxy card. You may revoke a proxy at any time prior to its exercise at the Annual Meeting by following the instructions in the “General Information Regarding the Annual Meeting and Voting” section of the accompanying Proxy Statement. If you attend the Annual Meeting, you may, if you wish, withdraw your proxy and vote in person. /s/ Paul A. Castanon Vice President, Deputy General Counsel and Corporate Secretary Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To Be Held on May 3, 2018 The accompanying Proxy Statement and the Company’s proxy card, as well as our Annual Report on Form 10-K for the year ended December 31, 2017, are available at www.proxyvote.com. TABLE OF CONTENTS Page PROXY STATEMENT SUMMARY ......................................................................... 1 PROPOSAL 1–ELECTION OF DIRECTORS ................................................................. 6 CORPORATE GOVERNANCE AND BOARD PRACTICES ..................................................... 13 DIRECTOR COMPENSATION ............................................................................ 20 SECURITIES OWNERSHIP ............................................................................... 22 HUMAN RESOURCES COMMITTEE REPORT .............................................................. 24 COMPENSATION DISCUSSION AND ANALYSIS ........................................................... 25 EXECUTIVE COMPENSATION TABLES ................................................................... 43 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS ......................... 59 PROPOSAL 2–ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION ................................. 60 AUDIT COMMITTEE REPORT ............................................................................ 61 PROPOSAL 3–RATIFICATION OF THE SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS .... 63 PROPOSAL 4–SHAREHOLDER PROPOSAL TO URGE THE BOARD TO ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD BE AN INDEPENDENT DIRECTOR ....................................................... 64 GENERAL INFORMATION REGARDING THE ANNUAL MEETING AND VOTING ................................ 66 OTHER INFORMATION ................................................................................. 69 APPENDIX A–NON-GAAP FINANCIAL MEASURES ......................................................... A-1 This Proxy Statement includes certain non-GAAP measures, such as Adjusted EBITDA and Adjusted Free Cash Flow. Definitions of these measures and reconciliations to the most comparable GAAP measure are contained in Appendix A. PROXY STATEMENT SUMMARY Below are highlights of certain information in this Proxy Statement. As it is only a summary, please refer to the complete Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2017 before you vote. 2018 ANNUAL MEETING OF SHAREHOLDERS Date and Time: Record Date: Thursday, May 3, 2018, at 8:00 a.m. Central Time March 29, 2018 Place: Information: Tenet Corporate Headquarters This Proxy Statement, the Company’s proxy card and our Annual Report 1445 Ross Avenue, Suite 1400 on Form 10-K are available at www.proxyvote.com. Dallas, Texas 75202 VOTING MATTERS AND BOARD RECOMMENDATIONS BOARD’S PROPOSALS RECOMMENDATION PAGE Election of Eight Director Nominees (Proposal 1) Our Board of Directors (the “Board”) believes that the eight director nominees bring FOR each of the director nominees 6 a combination of diverse qualifications and skills that contributes to a well-rounded Board. Each director nominee has proven leadership ability, good judgment and valuable experience. Advisory Approval of the Company’s Executive Compensation (Proposal 2) Our Board believes that Tenet Healthcare Corporation’s (“Tenet” or the “Company”) executive compensation program design effectively aligns the interests of our Named Executive Officers with those of our shareholders by tying a significant portion of our Named Executive Officers’ compensation to Tenet’s performance and rewarding our Named Executive Officers for the creation of long-term value for FOR 60 Tenet’s shareholders. In addition, Tenet remains committed to requiring that our Named Executive Officers maintain ownership of a material amount of our stock, includes clawback provisions within all performance-based compensation payable to our Named Executive Officers and does not provide excise tax gross-ups. Because your vote is advisory, it will not be binding on the Board. However, the Board and the Human Resources Committee value your opinion and will review and consider the voting results when making future executive compensation decisions. Ratification of the Selection of Deloitte & Touche LLP as Independent Registered Public Accountants for 2018 (Proposal 3) The Audit Committee approved the appointment of Deloitte & Touche LLP as FOR 63 Tenet’s independent registered public accounting firm for 2018. The Audit Committee and the Board believe that the continued retention of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm is in the best interests of the Company and its shareholders. Shareholder Proposal to Urge the Board to Adopt a Policy that the Chairman of the Board be an Independent Director (Proposal 4) AGAINST 64 Our Board believes that Tenet has an independent leadership structure, including a strong independent Lead Director, and that it is in our shareholders’ interests for Tenet to maintain flexibility with respect to its leadership structure. TENET HEALTHCARE Š 2018 PROXY STATEMENT 1 PROXY STATEMENT SUMMARY 2017:
Recommended publications
  • Jan Feb 2012 HR.Pdf
    SPECIAL LEADERSHIP ISSUE: 11 Leading Health System CEOs Share Goals for 2012 p. 18 INSIDE Building on a Legacy of Exceptional Care Q&A With Mass General Hospital Review Hospital President BUSINESS & LEGAL ISSUES FOR HEALTH SYSTEM LEADERSHIP Dr. Peter Slavin p. 22 January/February 2012 • Vol. 2012 No. 1 Hospital Leadership is The Year Ahead: 40 of the a Culture, Most Powerful Not a Person 12 Challenges and Q&A With LifePoint Hospitals People in CEO Bill Carpenter p. 24 Opportunities for Hospitals in 2012 Healthcare Leadership By Rachel Fields By Molly Gamble Lessons From As some states challenge the Affordable “Little” Failures It may be difficult to believe, but 2012 means hospitals are only in the Care Act in court, others are pushing Q&A With Health Management second year of healthcare reform. Many call this time one of uncertainty, implementation of regulations under Associates CEO Gary Newsome which is true, but it also presents great opportunity for innovation, change the federal reform law. The healthcare p. 34 and growth. Some concepts of healthcare reform that once seemed novel industry in 2011 is a fragmented and fascinating place. Here are 40 people continued on page 8 Finances in the who have been instrumental in shap- Era of Population ing healthcare policy, trends and debate Health over the last year. Q&A With Kevin Lang and Steve 10 Ways for Hospitals and Mohr of Loma Linda University Mark T. Bertolini. Mark Bertolini is Medical Center p. 44 Health Systems to Increase chairman, CEO and president of Aet- na, a health insurance company with INDEX Profitability in 2012 more than $34 billion in 2010 revenue, a workforce of more than 34,000 and By Bob Herman Hospital-Physician operations in North America, Asia, Eu- Relationships & ACOs p.
    [Show full text]
  • Morningstar® Document Research℠
    Morningstar® Document Research℠ FORM 10-K TENET HEALTHCARE CORP - THC Filed: February 24, 2014 (period: December 31, 2013) Annual report with a comprehensive overview of the company The information contained herein may not be copied, adapted or distributed and is not warranted to be accurate, complete or timely. The user assumes all risks for any damages or losses arising from any use of this information, except to the extent such damages or losses cannot be limited or excluded by applicable law. Past financial performance is no guarantee of future results. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2013 OR o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No.) 1445 Ross Avenue, Suite 1400 Dallas, TX 75202 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common stock, $0.05 par value New York Stock Exchange 7 9 8% Senior Notes due 2014 New York Stock Exchange 1 9 4% Senior Notes due 2015 New York Stock Exchange 7 6 8% Senior Notes due 2031 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • Morningstar® Document Research℠
    Morningstar® Document Research℠ FORM 10-K405 TENET HEALTHCARE CORP - THC Filed: August 27, 1999 (period: May 31, 1999) Annual report filed under Regulation S-K Item 405 (Discontinued) The information contained herein may not be copied, adapted or distributed and is not warranted to be accurate, complete or timely. The user assumes all risks for any damages or losses arising from any use of this information, except to the extent such damages or losses cannot be limited or excluded by applicable law. Past financial performance is no guarantee of future results. -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------ FORM 10-K /X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED MAY 31, 1999. OR / / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NUMBER: I-7293 ------------------------ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) NEVADA 95-2557091 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 3820 STATE STREET 93105 SANTA BARBARA, CALIFORNIA (Zip Code) (Address of principal executive offices) AREA CODE (805) 563-7000 (Registrant's telephone number, including area code) SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH REGISTERED Common Stock................................................... New York Stock Exchange Pacific Stock Exchange Preferred Stock Purchase Rights................................ New York Stock Exchange Pacific Stock Exchange 9 5/8% Senior Notes due 2002................................... New York Stock Exchange 7 7/8% Senior Notes due 2003..................................
    [Show full text]
  • For Immediate Release Thursday, Sept. 25, 2003 Grassley
    For Immediate Release Thursday, Sept. 25, 2003 Grassley Expresses Concern Over Tenet’s Commitment to Meaningful Reforms WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, today expressed concern that the Tenet Healthcare Corporation may not be conducting the reforms necessary to ensure taxpayers and Medicare beneficiaries of the proper use of tax dollars and the appropriate treatment of Medicare beneficiaries in the future. Grassley sent a detailed letter to Tenet’s new chairman of the board outlining a series of management changes that do not appear to substantially affect the structure that led to hundreds of lawsuits and numerous investigations into alleged patient deaths and complications due to unnecessary angioplasties, coronary bypasses, and heart catheterizations at Tenet’s Redding Medical Center, as well as the billing of Medicare for apparently unnecessary services. Earlier this month, Grassley sent a detailed document request to the company seeking information about these allegations and its use of federal health care dollars. Referring to the company’s statement that “until we have made good on these promises, these are only words,” Grassley said, “I couldn’t agree more with that characterization.” The text of today’s letter follows. September 26, 2003 VIA FACSIMILE: (805) 563-7070 ORIGINAL BY U.S. MAIL Mr. Edward A. Kangas Chairman Tenet Healthcare Corporation 3820 State Street Santa Barbara, CA 93105 Dear Mr. Kangas: By letter dated, September 5, 2003, the Senate Finance Committee (Committee) advised Mr. Trevor Fetter, then Acting Chief Executive Officer and President, Tenet Healthcare Corporation (Tenet), that the Committee is investigating Tenet’s corporate governance practices with respect to federal healthcare programs.
    [Show full text]
  • Tenet Healthcare Corp. (THC) Q2 2015 Earnings Call
    Corrected Transcript 04-Aug-2015 Tenet Healthcare Corp. (THC) Q2 2015 Earnings Call Total Pages: 21 1-877-FACTSET www.callstreet.com Copyright © 2001-2015 FactSet CallStreet, LLC Tenet Healthcare Corp. (THC) Corrected Transcript Q2 2015 Earnings Call 04-Aug-2015 CORPORATE PARTICIPANTS Trevor Fetter Keith B. Pitts President, Chief Executive Officer & Director Vice Chairman Daniel J. Cancelmi Britt T. Reynolds Chief Financial Officer President-Hospital Operations William H. Wilcox Stephen M. Mooney Chief Executive Officer & Director, United Surgical Partners President & Chief Executive Officer, Conifer Health Solutions LLC International, Inc. ...................................................................................................................................................................................................................................................... OTHER PARTICIPANTS A.J. Rice Gary Lieberman UBS Securities LLC Wells Fargo Securities LLC Whit Mayo Matthew Richard Borsch Robert W. Baird & Co., Inc. (Broker) Goldman Sachs & Co. Dana Nentin Kevin Mark Fischbeck Deutsche Bank Securities, Inc. Bank of America Merrill Lynch Andrew Schenker Sarah James Morgan Stanley & Co. LLC Wedbush Securities, Inc. Sheryl R. Skolnick Mizuho Securities USA, Inc. 2 1-877-FACTSET www.callstreet.com Copyright © 2001-2015 FactSet CallStreet, LLC Tenet Healthcare Corp. (THC) Corrected Transcript Q2 2015 Earnings Call 04-Aug-2015 MANAGEMENT DISCUSSION SECTION Operator: Please standby. We're about to begin. Good day everyone and welcome to the Second Quarter 2015 Tenet Healthcare Earnings Conference Call. My name is Dana and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. The slides referred to in today's call are posted on the company's website. Please note the cautionary statement on forward-looking information included in the slides.
    [Show full text]
  • United States Securities and Exchange Commission
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2017 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 ________________________________________ _ TENET HEALTHCARE CORPORATION ( Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No.) 1445 Ross Avenue, Suite 1400 Dallas, TX 75202 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code) ________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common stock, $0.05 par value New York Stock Exchange 6.875% Senior Notes due 2031 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None ________________________________________________________ Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨ Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ¨ No x Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Proxy Statement; and ID! Shareholders Can Obtain an Admission Ticket and Directions to the Meeting by Contacting Our Investor Relations 4
    NOTICE OF 2018 ANNUAL MEETING OF SHAREHOLDERS Date and Time VOTING Wednesday, May 16, 2018 12:30 p.m. EDT Location One Hartford Plaza Hartford, CT 06155 By internet By toll-free telephone On behalf of the Board of Directors, I am pleased to invite you www.proxyvote.com 1-800-690-6903 to attend the Annual Meeting of Shareholders of The Hartford Financial Services Group, Inc. to be held in the Wallace Stevens Theater at our Home Office at 12:30 p.m. EDT. Voting Items Shareholders will vote on the following items of business: By mail 1. Elect a Board of Directors for the coming year; Follow instructions on In person your proxy card At the Annual Meeting 2. Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018; IMPORTANT INFORMATION IF YOU PLAN TO ATTEND THE MEETING IN PERSON: 3. Consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers as Please remember to bring your ticket and government issued disclosed in this proxy statement; and ID! Shareholders can obtain an admission ticket and directions to the meeting by contacting our Investor Relations 4. Act upon any other business that may properly come Department: before the Annual Meeting or any adjournment thereof. Email: [email protected] Record Date Telephone: (860) 547-2537 You may vote if you were a shareholder of record at the close of business on March 19, 2018. The Hartford’s proxy Mail: The Hartford materials are available via the internet, which allows us to Attn: Investor Relations reduce printing and delivery costs and lessen adverse One Hartford Plaza (TA1-1) environmental impacts.
    [Show full text]
  • Hartford Proxy 2018
    THE HARTFORD DOING THE RIGHT THING. IMPACTING THE WORLD AROUND US. It’s fundamental to our culture: Doing the right thing every day and in every situation. And while our efforts do REPORT ANNUAL AND 2017 STATEMENT MEETING OF SHAREHOLDERS, PROXY ANNUAL OF 2018 NOTICE award us recognition, the real reward is the impact we make on our employees, our customers and our communities. World’s Most Ethical Companies®, Ethisphere Institute (2018) Best Place to Work for Lesbian, Gay, Bisexual and Transgender (LGBT) Equality, Human Rights Campaign, Corporate Equality Index (2017) Military Friendly Employer, Military Times (2017) 2017 Bloomberg Financial Services Gender-Equality Index (BFGEI) The Hartford Named A Best Employer For Healthy Lifestyles®, National Business Group (2017) 100% Disability Equality Index, Best Place to Work (2017) LEARN MORE ABOUT US AT thehartford.com/our-company NOTICE OF 2018 ANNUAL MEETING OF SHAREHOLDERS, PROXY STATEMENT AND 2017 ANNUAL REPORT FOLLOW THE HARTFORD ON THE HARTFORD IS THE OFFICIAL DISABILITY INSURANCE SPONSOR OF U.S. PARALYMPICS 1 Based on The Hartford’s internal reporting as of December 2017 combined with the Aetna acquisition. 2 Customer reviews were collected and tabulated by The Hartford and reviews are not representative of all customers. The Hartford® is The Hartford Financial Services Group, Inc. and its subsidiaries, including issuing companies, Hartford Fire Insurance Company, Hartford Life Insurance Company and Hartford Life and Accident Insurance Company. Its headquarters is in Hartford, CT. 17-1329 © February 2018 The Hartford 36USC220506 334622_Hartford_2018_Proxy_Cover_R1.indd 2-4 3/28/18 10:08 PM RINGING IN ANOTHER YEAR OF OUR COMMITMENT TO FIRE SAFETY.
    [Show full text]
  • Morningstar® Document Research℠
    Morningstar® Document Research℠ FORM 10-K TENET HEALTHCARE CORP - THC Filed: February 26, 2013 (period: December 31, 2012) Annual report with a comprehensive overview of the company The information contained herein may not be copied, adapted or distributed and is not warranted to be accurate, complete or timely. The user assumes all risks for any damages or losses arising from any use of this information, except to the extent such damages or losses cannot be limited or excluded by applicable law. Past financial performance is no guarantee of future results. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2012 OR o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No.) 1445 Ross Avenue, Suite 1400 Dallas, TX 75202 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common stock New York Stock Exchange 3 7 8% Senior Notes due 2013 New York Stock Exchange 7 9 8% Senior Notes due 2014 New York Stock Exchange 1 9 4% Senior Notes due 2015 New York Stock Exchange 7 6 8% Senior Notes due 2031 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • 14Th Annual Compliance Institute April 18–21, 2010 ✪ Hyatt Regency ✪ Dallas, TX
    Group Discounts AvAilAble (see page 43) HealtH Care ComplianCe assoCiation’s 14th annual ComPlianCe institute april 18–21, 2010 ✪ Hyatt regency ✪ Dallas, tX Final Program register now at www.ComPlianCe-institute.org HCCa would like to thank our affinity group ConFerenCe sPonsors meetings in 2010 plAtinuM sponsors Hold your organization’s meeting in conjunction with HCCa’s Compliance institute! BeneFit: Holding your meeting in Dallas will enable your members/staff to network at the largest conference for health care GolD sponsors compliance professionals. DisCounts: All members from your orga- nization will receive the HCCA member rate to the 2010 Compliance Institute. Book your meeting: HCCA will hold the 2010 Compliance Institute at the Hyatt Dallas at Reunion. Approved applica- tions receive complimentary meeting silver sponsors room space at the conference site and your choice of complimentary continen- tal breakfast or am or pm break. Please arrange additional food and beverage conFerence SUPPORTERS directly with the hotel. Affinity group meetings may be held: • Saturday, April 17 • Wednesday, April 21 MeDiA sponsors • Thursday, April 22 Contact Jennifer Power at 952-405-7916 or [email protected] to learn more 2 www.compliance-institute.org about the institute Join your Colleagues in Dallas for the single most comprehensive compliance conference designed specifically to meet the needs of today’s healthcare compliance professionals and their staff. learning objectives who should attend • To describe the various components
    [Show full text]
  • Nursing Homes Can Boost Quality, Bottom Line with ‘Consistent Assignment’
    Single Use Only. Contact Modern Healthcare for reprint rights | http://www.modernhealthcare.com/reprints Single Use Only. Contact Modern Healthcare for reprint rights | http://www.modernhealthcare.com/reprints How do you hire 200 executives for a single position? B. E. resourceful. When you fill an executive vacancy with an Interim Leader from B. E. Smith, you gain the benefits of at least 20 years of healthcare executive experience, and much more. Because every B. E. Smith Interim is supported by the resources and best practices of all 200 leaders that we employ. To find the right Interim Leader for your needs, visit BESmith.com or call 877-802-4593. Experience. Speed. Results. Guaranteed. INTERIM LEADERSHIP | EXECUTIVE SEARCH | CONSULTING SOLUTIONS Single Use Only. Contact Modern Healthcare for reprint rights | http://www.modernhealthcare.com/reprints Editorial EDITORS David Burda editor 312-649-5439 / [email protected] Neil McLaughlin managing editor 312-649-5343 / [email protected] AUGUST 16, 2010 Paul Barr news editor 312-649-5230 / [email protected] David May assistant managing editor/features COVER STORY 312-649-5451 / [email protected] With more government involvement comes more Keith Horist assistant managing editor/graphics 312-649-5467 / [email protected] government attention. That’s the lesson about executive ONLINE pay healthcare CEOs could learn as the reform law and Pat Shrader online editor its ramifications settle into place. “It’s important for the 312-649-5418 / [email protected] people who are scraping together the dollars to pay Christine LaFave Grace webmaster/copy editor 312-649-5225 / [email protected] their health insurance premiums to know what luxurious REPORTERS lives these CEOs are leading.
    [Show full text]
  • Late File Exhibit 4 and Late File Exhibit 5
    PULLMAN &COMLEYLic Karen A. Daley ATTORNEYS 850 Main Street P.O. Box 7006 Bridgeport, CT 06601-7006 p 203 330 2143 f 203 576 8888 [email protected] www.pulleom.com November 5, 2014 VIA HAND DELIVERY Office of the Attorney General 55 Elm Street, P.O. Box 120 Hartford, CT 06141-0120 Attn.: Gary W. Hawes, Esq., Assistant Attorney General Office of Health Care Access, Department of Public Health 410 Capitol Avenue Hartford, CT 06134 Attn.: Steven W. Lazarus RE: Proposal for Joint Venture between Greater Waterbury Health Network, Inc. and Vanguard Health Systems, Inc. OHCA Docket No. 13-31838-486 Attorney General Docket No. 13-486-01 Dear Attorney Hawes and Mr. Lazarus: The Greater Waterbury Health Network ("GWHN") and Tenet Healthcare Corporation ("Tenet") hereby submit the following Late File Exhibits: Late File Exhibit 4: Tenet Form Q10 for Third Quarter Late File Exhibit 5: GWHN Charitable Foundation — net Foundation assets before and after adjustments to the purchase price The original, three (3) hard copies and one (1) electronic copy of these filings will be hand delivered to Mr. Lazarus' office. Two (2) hard copies and one (1) electronic copy will be hand delivered to Attorney Hawes' office. 0-0057 WWW.PULLCOM.COM I BRIDGEPORT I HARTFORD I STAMFORD I WATERBURY I WHITE PLAINS PULLMAN &COMLEY,L, ATTORNEYS Page 2 Please contact me if you have any questions or need anything further. Thank you for your assistance in this matter. Very truly yours, Pullman & Comley LLC Enclosures ACTIVE/76178.1/KDALEY/4876682v1 00058 Joint Venture between Greater Waterbury Health Network, Inc.
    [Show full text]